triethylenemelamine has been researched along with Syndrome in 2 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KOYAMA, Y | 1 |
| KONO, M | 1 |
| TAKEMASA, Y | 1 |
| HUKUDA, R | 1 |
| AMAKI, I | 1 |
| Winkelmann, RK | 1 |
| Perry, HO | 1 |
| Muller, SA | 1 |
| Schroeter, AL | 1 |
| Jordon, RE | 1 |
| Rogers, RS | 1 |
2 other studies available for triethylenemelamine and Syndrome
| Article | Year |
|---|---|
[Studies on the treatment of malignant disease. V].
Topics: Antineoplastic Agents; Neoplasms; Syndrome; Triethylenemelamine | 1956 |
Treatment of Sezary syndrome.
Topics: Chlorambucil; Cyclophosphamide; Dermatitis, Exfoliative; Humans; Keratoderma, Palmoplantar; Lymphati | 1974 |